Whole exome/genome sequencing studies of MF/SS patients have suggested that somatic mutations in genes involved in TCR/NFκB signaling, Th2 differentiation, apoptosis, chromatin modifying genes, and cell-cycle control are important for development of the disease [40,41]. This evidence concerns the gene NFKB1 and synovial sarcoma.